Novozymes and Chr. Hansen to Merge
Danish companies Novozymes and Chr. Hansen have agreed to merge, in a move they termed a perfect match that will create a global leader in biosolutions.
Novozymes
Novozymes and Saipem Collaborate on Enzymatic Carbon Capture
Danish biotech Novozymes and Italian engineering company Saipem have agreed to collaborate on the development and commercialization of an enzymatic carbon capture process, a biological alternative to traditional carbon capture.
Novozymes and Novo Nordisk Partner on Enzymes
Danish companies Novozymes and Novo Nordisk Pharmatech are teaming up to develop technical enzymes to support biopharma processing. The companies aim to develop high-quality enzymatic processing aids for the regenerative medicines market, focusing on stem cell and gene therapies.
Novozymes and Anuvia Partner on Plant Biotech
Danish biotech Novozymes has linked up with US-based Anuvia Plant Nutrients to develop a range of combined biotechnologies to reduce the need for synthetic fertilizers in commercial agriculture. As a first step, the companies will combine Novozymes’ phosphate solubilizing microbial solutions with Anuvia’s bio-based fertilizer products to enhance macronutrient efficiency with a focus on phosphate.
Novozymes Boosts Microbiome with Biota Buy
Novozymes has acquired Biota’s microbiome R&D team and data science platform for an undisclosed sum. The move builds on two previous deals in the microbiome field this past year, notably of US-based Microbiome Labs and Ireland’s PrecisionBiotics.
Novozymes and FMC Link on Biological Pest Control
Danish biotech Novozymes has announced a collaboration with US agricultural sciences group FMC to research, develop and commercialize biological enzyme-based crop protection solutions. The move is part of Novozymes’ entry into the biocontrol segment, using its new enzyme-based technology.
Novozymes Buys Microbiome Labs
Novozymes is to buy US-based Microbiome Labs, strengthening the Danish biotech’s presence in probiotics and gaining entry into the important North American market. The transaction is expected to close in the first half of January 2021.
Novozymes Boosts Gut Health with PrecisionBiotics
Danish biotech Novozymes has acquired Ireland’s PrecisionBiotics Group for €80 million on a cash and debt-free basis.
Syngenta and Novozymes Win Taegro Approvals
After more than seven years of collaboration, Syngenta and Novozymes are now entering the commercialization phase of their microbial-based foliar fungicide Taegro.
